PIGG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.167400E-01
Normal-vs-Stage2
7.763200E-01
Normal-vs-Stage3
8.026000E-02
Normal-vs-Stage4
4.878600E-01
Stage1-vs-Stage2
5.965200E-01
Stage1-vs-Stage3
8.729700E-02
Stage1-vs-Stage4
6.525800E-01
Stage2-vs-Stage3
3.418200E-02
Stage2-vs-Stage4
3.434600E-01
Stage3-vs-Stage4
1.637360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.658400E-01
Normal-vs-AfricanAmerican
8.875000E-01
Normal-vs-Asian
3.501400E-01
Caucasian-vs-AfricanAmerican
7.413800E-01
Caucasian-vs-Asian
3.283400E-01
AfricanAmerican-vs-Asian
3.416400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.412000E-01
Normal-vs-Female
5.563000E-01
Male-vs-Female
3.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.036600E-01
Normal-vs-Age(41-60Yrs)
9.153800E-01
Normal-vs-Age(61-80Yrs)
7.527200E-01
Normal-vs-Age(81-100Yrs)
2.640800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.165400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.519200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.450000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.952000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.986300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.891000E-01
Normal-vs-Daily Drinker
8.844400E-01
Normal-vs-Weekly Drinker
3.352800E-01
Normal-vs-Occasional Drinker
5.656400E-01
Normal-vs-Social Drinker
9.160400E-01
Non Drinker-vs-Daily Drinker
2.205600E-01
Non Drinker-vs-Weekly Drinker
8.586400E-01
Non Drinker-vs-Occasional Drinker
5.919900E-03
Non Drinker-vs-Social Drinker
1.849780E-01
Daily Drinker-vs-Weekly Drinker
2.667800E-01
Daily Drinker-vs-Occasional Drinker
2.612200E-01
Daily Drinker-vs-Social Drinker
9.184200E-01
Weekly Drinker-vs-Occasional Drinker
9.335500E-03
Weekly Drinker-vs-Social Drinker
2.035200E-01
Occasional Drinker-vs-Social Drinker
2.885800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.528600E-01
Normal-vs-Grade 2
6.984200E-01
Normal-vs-Grade 3
6.310000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.797200E-01
Grade 1-vs-Grade 3
7.455600E-01
Grade 1-vs-Grade 4
2.528600E-01
Grade 2-vs-Grade 3
4.553400E-01
Grade 2-vs-Grade 4
6.984200E-01
Grade 3-vs-Grade 4
6.310000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.096600E-01
Normal-vs-NonDiabetic
6.191800E-01
Diabetic-vs-NonDiabetic
2.655000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.522200E-01
Normal-vs-NoPancreatitis
7.309800E-01
Pancreatitis-vs-NoPancreatitis
3.599200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.758000E-01
Normal-vs-N1
7.571400E-01
N0-vs-N1
5.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.310800E-01
Normal-vs-TP53-NonMutant
8.356000E-01
TP53-Mutant-vs-TP53-NonMutant
2.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
